Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03755518
Brief Title: A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis and Previously Treated With Ruxolitinib (FREEDOM)

First Submitted : November 8, 2018
First Submitted that Met QC Criteria : November 26, 2018
First Posted : November 28, 2018

Last Update Submitted that Met QC Criteria : May 10, 2022
Last Update Posted : May 16, 2022